Young patients with intraductal papillary mucinous neoplasms (IPMNs) show excellent long-term quality of life after pancreatic surgery, informing surgical decision-making.

• 63% needed pancreatic enzyme replacement; 16% developed insulin-dependent diabetes.
• Quality of life scores (global health 71.1%, functioning 82.9%) were similar to age-matched peers.

Parenchyma-sparing resections yielded particularly favorable outcomes, boosting confidence in surgical options for this demographic.